207 related articles for article (PubMed ID: 8188756)
1. Type-1 insulin-like growth factor receptor overexpression produces dual effects on myoblast proliferation and differentiation.
Quinn LS; Steinmetz B; Maas A; Ong L; Kaleko M
J Cell Physiol; 1994 Jun; 159(3):387-98. PubMed ID: 8188756
[TBL] [Abstract][Full Text] [Related]
2. Ligand-dependent inhibition of myoblast differentiation by overexpression of the type-1 insulin-like growth factor receptor.
Quinn LS; Ehsan M; Steinmetz B; Kaleko M
J Cell Physiol; 1993 Sep; 156(3):453-61. PubMed ID: 7689569
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the human type-1 insulin-like growth factor receptor in rat L6 myoblasts induces ligand-dependent cell proliferation and inhibition of differentiation.
Quinn LS; Roh JS
Exp Cell Res; 1993 Oct; 208(2):504-8. PubMed ID: 8375479
[TBL] [Abstract][Full Text] [Related]
4. Retrovirally mediated overexpression of insulin-like growth factor binding protein 4: evidence that insulin-like growth factor is required for skeletal muscle differentiation.
Damon SE; Haugk KL; Birnbaum RS; Quinn LS
J Cell Physiol; 1998 Apr; 175(1):109-20. PubMed ID: 9491786
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of the type-1 insulin-like growth factor receptor increases ligand-dependent proliferation and differentiation in bovine skeletal myogenic cultures.
Quinn LS; Haugk KL
J Cell Physiol; 1996 Jul; 168(1):34-41. PubMed ID: 8647920
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor II overexpression in myoblasts induces phenotypic changes typical of the malignant phenotype.
Minniti CP; Luan D; O'Grady C; Rosenfeld RG; Oh Y; Helman LJ
Cell Growth Differ; 1995 Mar; 6(3):263-9. PubMed ID: 7794794
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-alpha and basic fibroblast growth factor differentially inhibit the insulin-like growth factor-I induced expression of myogenin in C2C12 myoblasts.
Layne MD; Farmer SR
Exp Cell Res; 1999 May; 249(1):177-87. PubMed ID: 10328964
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta isoform expression in insulin-like growth factor stimulated myogenesis.
Bosche WJ; Ewton DZ; Florini JR
J Cell Physiol; 1995 Aug; 164(2):324-33. PubMed ID: 7542663
[TBL] [Abstract][Full Text] [Related]
9. The influence of growth factors on turkey embryonic myoblasts and satellite cells in vitro.
McFarland DC; Pesall JE; Gilkerson KK
Gen Comp Endocrinol; 1993 Mar; 89(3):415-24. PubMed ID: 7687577
[TBL] [Abstract][Full Text] [Related]
10. Rabbit slow and fast skeletal muscle-derived satellite myoblast phenotypes do not involve constitutive differences in the components of the insulin-like growth factor system.
Barjot C; Navarro M; Cotten ML; Garandel V; Bernardi H; Bacou F; Barenton B
J Cell Physiol; 1996 Nov; 169(2):227-34. PubMed ID: 8908189
[TBL] [Abstract][Full Text] [Related]
11. Developmental regulation of Mac25/insulin-like growth factor-binding protein-7 expression in skeletal myogenesis.
Damon SE; Haugk KL; Swisshelm K; Quinn LS
Exp Cell Res; 1997 Nov; 237(1):192-5. PubMed ID: 9417882
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factors (IGF-I and IGF-II) inhibit C2 skeletal myoblast differentiation and enhance TNF alpha-induced apoptosis.
Foulstone EJ; Meadows KA; Holly JM; Stewart CE
J Cell Physiol; 2001 Nov; 189(2):207-15. PubMed ID: 11598906
[TBL] [Abstract][Full Text] [Related]
13. Actions of transforming growth factor-beta on muscle cells.
Florini JR; Ewton DZ
J Cell Physiol; 1988 May; 135(2):301-8. PubMed ID: 3163695
[TBL] [Abstract][Full Text] [Related]
14. IGF-II is more active than IGF-I in stimulating L6A1 myogenesis: greater mitogenic actions of IGF-I delay differentiation.
Ewton DZ; Roof SL; Magri KA; McWade FJ; Florini JR
J Cell Physiol; 1994 Nov; 161(2):277-84. PubMed ID: 7962112
[TBL] [Abstract][Full Text] [Related]
15. Regulation of skeletal muscle satellite cell proliferation and differentiation by transforming growth factor-beta, insulin-like growth factor I, and fibroblast growth factor.
Allen RE; Boxhorn LK
J Cell Physiol; 1989 Feb; 138(2):311-5. PubMed ID: 2918032
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-15 stimulates C2 skeletal myoblast differentiation.
Quinn LS; Haugk KL; Damon SE
Biochem Biophys Res Commun; 1997 Oct; 239(1):6-10. PubMed ID: 9345260
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor I (IGF-I) receptor overexpression abolishes the IGF requirement for differentiation and induces a ligand-dependent transformed phenotype in C2 inducible myoblasts.
Navarro M; Barenton B; Garandel V; Schnekenburger J; Bernardi H
Endocrinology; 1997 Dec; 138(12):5210-9. PubMed ID: 9389503
[TBL] [Abstract][Full Text] [Related]
18. Partial characterization of skeletal myoblast mitogens in mouse crushed muscle extract.
Chen G; Quinn LS
J Cell Physiol; 1992 Dec; 153(3):563-74. PubMed ID: 1447318
[TBL] [Abstract][Full Text] [Related]
19. Concerted regulation of early enterocyte differentiation by insulin-like growth factor I, insulin, and transforming growth factor-beta1.
Kojima H; Hidaka H; Matsumura K; Fujita Y; Nishio Y; Maegawa H; Haneda M; Yasuda H; Fujimiya M; Kikkawa R; Kashiwagi A
Proc Assoc Am Physicians; 1998; 110(3):197-206. PubMed ID: 9625526
[TBL] [Abstract][Full Text] [Related]
20. Effect of recombinant porcine IGFBP-3 on IGF-I and long-R3-IGF-I-stimulated proliferation and differentiation of L6 myogenic cells.
Xi G; Kamanga-Sollo E; Pampusch MS; White ME; Hathaway MR; Dayton WR
J Cell Physiol; 2004 Sep; 200(3):387-94. PubMed ID: 15254966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
